News
-
![]()
Development of a multi-entity chip with mobile measurement system for minimally invasive early cancer detection
The University of Lübeck, together with the project partners CAMPTON Diagnostics and soventec as well as the University Hospital of Schleswig-Holstein (UKSH), receives funding from the state program Economy for a project on the early detection of pancreatic, colorectal and lung cancer Itzehoe, 31.05.2021 – The University of Lübeck, the biotechnology company CAMPTON Diagnostics GmbH,…
-
![]()
LIFE SCIENCE NORD features CAMPTON in new issue of their magazine.
LIFE SCIENCE NORD features Campton in the new issue of its magazine. Read the article here (PDF).
-
![]()
CAMPTON is a partner of Schleswig-Holstein – The Real North. Portrait of Itzehoe shows CAMPTON on film.
CAMPTON Diagnostics is a partner of the state umbrella brand “Schleswig-Holstein. The real North.” CAMPTON Diagnostics now presents itself in a film as part of a location portrait. The brand communicates Schleswig-Holstein’s locational advantages to the outside world and offers a strong identification symbol. https://der-echte-norden.info
-
![]()
MEDICA 2020: CAMPTON Diagnostics presents fully automated point-of-care platform for fast test results
CAMPTON Reader 100 enables the detection of biomarkers e.g. for infections, cancer, autoimmune or other diseases from a whole blood sample within a few minutes Serological and molecular biological tests for corona in preparation Itzehoe, 16.11.2020 – At this year’s MEDICA, CAMPTON Diagnostics will present the first generation of its CAMPTON Reader 100, a point-of-care…
-
![]()
CAMPTON launches new website
Wir freuen uns, unsere neue Website zu eröffnen! Mit einem modernen und klaren Erscheinungsbild haben wir unsere Website neu gestaltet und hoffen, dass sie Ihnen gefällt!
-
![]()
CAMPTON at virtual.MEDICA
From 16th to 19th November, we will be presenting our CAMPTON Reader 100, a new point-of-care technology to quickly and reliably identify cancer, infectious and autoimmune diseases, at the virtual MEDICA – Leading International Trade Fair. We are looking forward to seeing you! Are you interested? Then please contact us or visit us at MEDICA.
-
![]()
CAMPTON Diagnostics develops molecular biological and serological test for CORONA on Reader 100 for almost simultaneous measurement of both tests
The aim of the development work is to have both test variants available by around September 2020. The technology of our reader was originally developed for the protein analysis procedure and is currently being extended to DNA analysis. At present, we are not aware of any competing system on the market that can measure with…
-
![]()
Campton has been recognized as Top 10 In Vitro Diagnostics Solutions Provider in Europe
Campton has been recognized as Top 10 In Vitro Diagnostics Solutions Provider in Europe. Read the full article here: https://in-vitro-diagnostics-europe.medicaltechoutlook.com/vendor/campton-diagnostics-the-new-age-diagnostics-system-cid-671-mid-67.html
-
![]()
CAMPTON Diagnostics wins the Würth Group as investor
Würth Group participates in second financing round of Campton Diagnostics. Newcomer On-site diagnostics help to identify diseases quickly and provide better care for patients Würth Group participates in second financing round of Campton Diagnostics. Newcomer On-site diagnostics help to identify diseases quickly and provide better care for patients Itzehoe, 09.07.2019 – CAMPTON Diagnostics GmbH (“CAMPTON”)…
-
![]()
Campton Diagnostics – founded 2016
CAMPTON Diagnostics was founded in 2016 at Fraunhofer ISIT in Itzehoe. CAMPTON develops highly sensitive in-vitro diagnostics, for which ISIT manufactures the biochips in the institute’s own cleanroom. Within a few minutes, CAMPTON’s point-of-care system can use a drop of whole blood to make reliable predictions about infections, cancer or other diseases. The robust system…
